Trial Details
COMPLETEDBasic Information
| Clinical ID | c1333 |
|---|---|
| Identifier | NCT01988961 |
| Trial Title | A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | BIOLOGICAL: Golimumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | La Jolla |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-12-13 |
|---|---|
| Primary Completion Date | 2025-02-15 |
| Completion Date | 2025-01-16 |